ARCHIVES

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

New Breast Cancer Therapies Move Into General Practice; Fisher, Miami Plan Segmental Trials

February 13, 1976

DES Study Indicates Threat If Vaginal Cancer May Not Be Serious

November 15, 1974

NCI Formaldehyde Finding Criticized

March 7, 1986

In Brief: FDA Seeks Applicants For Oncology Div. Head; Croce Wins Pasarow Award; CRI Honors Five

August 18, 1995

Congress Investigates “Lecture Awards” To Former NCI Director Richard Klausner.

July 4, 2003

USLA’’s Steckel Asks More Centers Staff, Strict Enforcement of Guidelines

February 17, 1978